$1.44
-0.07-4.64%
At close: -
$1.44
0.000.00%
After Hours: 7:48 PM EDT
Theriva Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Theriva Biologics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-6.81 | $-6.25 | -8.96 % |
Q2 | 2024-08-13 | $-5.50 | $-7.00 | 21.4 % |
Q1 | 2024-05-07 | $-7.50 | $-8.50 | 11.8 % |
Q4 | 2024-03-25 | $-8.25 | $-10.25 | 19.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Theriva Biologics (TOVX) is scheduled to report earnings on March 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-6.81, which missed the estimate of $-6.25.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.